Triochem Product

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE331E01013
  • NSEID:
  • BSEID: 512101
INR
17.40
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 0

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 168942,
    "name": "Triochem Product",
    "stock_name": "Triochem Product",
    "full_name": "Triochem Products Ltd",
    "name_url": "stocks-analysis/triochem-product",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.40",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "17.40",
    "mcapval": "",
    "mcap": "Micro Cap",
    "scripcode": 512101,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE331E01013",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "0 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/triochem-product-168942-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "168942",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/triochem-products-168942"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Nov-2026",
      "details": "Unaudited Financial Results for the quarter and half year ended 30th September 2026 publice on Navshakti and Fee Press Journal on 5th November 2026 which is prroved by the Board in Its meeting on 4th November 2026",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2026",
      "datetime": "04-Nov-2026",
      "details": "The Board of Director of the Company at its meeting held today wednesday 4th November 2026 have inter-alia considered and approved the Unaudited Standalone Financial Results for the quarter and half year ened 30th September 2026 revired by the Audit Committee along with Statement of Assets and Liabilities as at 30th September 2026 and Cash Flow Statement for hte period ended 30th September 2026 along with Limited Review Report submitted by the Statutory Auditors of the Compnay",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015.",
      "datetime": "04-Nov-2026",
      "details": "Not Applicable as there is no offer made by way of publice issue right issue preferential issue etc",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Unaudited Financial Results for the quarter and half year ended 30th September 2026 publice on Navshakti and Fee Press Journal on 5th November 2026 which is prroved by the Board in Its meeting on 4th November 2026

Submission Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2026

04-Nov-2026 | Source : BSE

The Board of Director of the Company at its meeting held today wednesday 4th November 2026 have inter-alia considered and approved the Unaudited Standalone Financial Results for the quarter and half year ened 30th September 2026 revired by the Audit Committee along with Statement of Assets and Liabilities as at 30th September 2026 and Cash Flow Statement for hte period ended 30th September 2026 along with Limited Review Report submitted by the Statutory Auditors of the Compnay

Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015.

04-Nov-2026 | Source : BSE

Not Applicable as there is no offer made by way of publice issue right issue preferential issue etc

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available